Traws Pharma (TRAW) Misses Q3 EPS by 34c
Tweet
Share
E-mailGet Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma (NASDAQ: TRAW) reported Q3 EPS of ($0.34).
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla readies August launch of CyberCab - The Information
- Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
- Coherent starts sampling 300mm silicon carbide substrates for AI chips
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
